Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Talis Biomedical Corp (TLIS)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.1 | 1.3 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -392.0% | -500.7% | -350.8% | -2028.8% | |
ROIC (including intangibles) | -349.6% | -743.4% | -179.4% | -2277.7% | -1468.1% |
ROE | -90.8% | -82.0% | -50.0% | -123.5% | -278.5% |
ROA | -68.0% | -72.2% | -46.0% | -103.8% | -188.3% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Days payables outstanding | 163.9 | | | 18.6 | 23.1 |
Cash conversion cycle | -163.9 | | | -18.6 | -23.1 |
|